Characteristics of HL patients
| Characteristic . | Value . |
|---|---|
| Median age, y (range) | 45 (20-65) |
| Sex, M/F | 11/14 |
| Histology | |
| NS | 15 (60%) |
| MC | 10 (40%) |
| Site | |
| Cervical | 12 |
| Axillary | 5 |
| Inguinal | 8 |
| Gene expression | |
| PAX5 | 10 |
| IRF4/MUM1 | 6 |
| EBV-LMP1 | 4 |
| Characteristic . | Value . |
|---|---|
| Median age, y (range) | 45 (20-65) |
| Sex, M/F | 11/14 |
| Histology | |
| NS | 15 (60%) |
| MC | 10 (40%) |
| Site | |
| Cervical | 12 |
| Axillary | 5 |
| Inguinal | 8 |
| Gene expression | |
| PAX5 | 10 |
| IRF4/MUM1 | 6 |
| EBV-LMP1 | 4 |
Twenty-five patients with cHL according to the WHO classification were analyzed. The EBV status of HL nodes was assessed by immunostaining fixed sections of diagnostic node with a mixture of antibodies against EBV-expressed latent membrane protein-1.
M indicates male; F, female; NS, nodular sclerosis, and MC, mixed cellularity.